162 related articles for article (PubMed ID: 8303210)
1. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer?
Røseth AG; Kristinsson J; Fagerhol MK; Schjønsby H; Aadland E; Nygaard K; Roald B
Scand J Gastroenterol; 1993 Dec; 28(12):1073-6. PubMed ID: 8303210
[TBL] [Abstract][Full Text] [Related]
2. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin concentration in patients with colorectal carcinoma.
Kristinsson J; Røseth A; Fagerhol MK; Aadland E; Schjønsby H; Børmer OP; Raknerud N; Nygaard K
Dis Colon Rectum; 1998 Mar; 41(3):316-21. PubMed ID: 9514426
[TBL] [Abstract][Full Text] [Related]
4. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics.
Kristinsson J; Armbruster CH; Ugstad M; Kriwanek S; Nygaard K; Tøn H; Fuglerud P
Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414
[TBL] [Abstract][Full Text] [Related]
5. Faecal calprotectin levels in a high risk population for colorectal neoplasia.
Kronborg O; Ugstad M; Fuglerud P; Johne B; Hardcastle J; Scholefield JH; Vellacott K; Moshakis V; Reynolds JR
Gut; 2000 Jun; 46(6):795-800. PubMed ID: 10807890
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of fecal calprotectin as a screening biomarker for gastrointestinal malignancies.
Khoshbaten M; Pishahang P; Nouri M; Lashkari A; Alizadeh M; Rostami-Nejad M
Asian Pac J Cancer Prev; 2014; 15(4):1667-70. PubMed ID: 24641386
[TBL] [Abstract][Full Text] [Related]
7. Faecal calprotectin as a marker for oesophago-gastric cancer.
Vincent Z; Hornby S; Ball S; Sanders G; Ayling RM
Ann Clin Biochem; 2015 Nov; 52(Pt 6):660-4. PubMed ID: 25732128
[TBL] [Abstract][Full Text] [Related]
8. Fecal marker variability in colorectal cancer: calprotectin versus hemoglobin.
Gilbert JA; Ahlquist DA; Mahoney DW; Zinsmeister AR; Rubin J; Ellefson RD
Scand J Gastroenterol; 1996 Oct; 31(10):1001-5. PubMed ID: 8898421
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study.
Røseth AG; Fagerhol MK; Aadland E; Schjønsby H
Scand J Gastroenterol; 1992 Sep; 27(9):793-8. PubMed ID: 1411288
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathological correlations of fecal calprotectin release in colorectal carcinoma.
Lehmann FS; Trapani F; Fueglistaler I; Terracciano LM; von Flüe M; Cathomas G; Zettl A; Benkert P; Oertli D; Beglinger C
World J Gastroenterol; 2014 May; 20(17):4994-9. PubMed ID: 24803811
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
[TBL] [Abstract][Full Text] [Related]
13. Assessment of ileal pouch inflammation by single-stool calprotectin assay.
Thomas P; Rihani H; Røseth A; Sigthorsson G; Price A; Nicholls RJ; Bjarnason I
Dis Colon Rectum; 2000 Feb; 43(2):214-20. PubMed ID: 10696896
[TBL] [Abstract][Full Text] [Related]
14. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.
Turvill J; Aghahoseini A; Sivarajasingham N; Abbas K; Choudhry M; Polyzois K; Lasithiotakis K; Volanaki D; Kim B; Langlands F; Andrew H; Roos J; Mellen S; Turnock D; Jones A
Br J Gen Pract; 2016 Jul; 66(648):e499-506. PubMed ID: 27266863
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients.
Widlak MM; Thomas CL; Thomas MG; Tomkins C; Smith S; O'Connell N; Wurie S; Burns L; Harmston C; Evans C; Nwokolo CU; Singh B; Arasaradnam RP
Aliment Pharmacol Ther; 2017 Jan; 45(2):354-363. PubMed ID: 27910113
[TBL] [Abstract][Full Text] [Related]
16. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
17. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of NSAID enteropathy as shown by a simple faecal test.
Tibble JA; Sigthorsson G; Foster R; Scott D; Fagerhol MK; Roseth A; Bjarnason I
Gut; 1999 Sep; 45(3):362-6. PubMed ID: 10446103
[TBL] [Abstract][Full Text] [Related]
19. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
20. Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms.
Mowat C; Digby J; Strachan JA; Wilson R; Carey FA; Fraser CG; Steele RJ
Gut; 2016 Sep; 65(9):1463-9. PubMed ID: 26294695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
